TP53 and breast carcinoma: Chromatin ImmunoPrecipitation (ChIP)-on-chip experiments and expression arrays using SKBR3 breast cancer cells with the p53R175H mutation identified mutant p53 complexes with the vitamin D receptor which augmented expression of survival genes and dampened expression of proapoptotic genes (42).